JNJ-90301900 (NBTXR3) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Functionalized hafnium oxide nanoparticles, NBTXR3

Filter by location:

Birmingham, Alabama1 trial

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

University of Alabama at Birmingham

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.